Arrowhead Acquires Novartis’ RNAi Research and Development Portfolio
Go back to Arrowhead Acquires Novartis’ RNAi Research and Development Portfolio| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 79.47 +0.58 (0.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $78.89 | 52 Week High | $8.22 | |||
| Open | $79.79 | 52 Week Low | $3.07 | |||
| Day High | $80.52 | P/E | N/A | |||
| Day Low | $78.17 | EPS | $-1.30 | |||
| Volume | 713,907 | |||||
